GoodRx Holdings (GDRX) Non-Current Assets (2019 - 2026)

GoodRx Holdings has disclosed Non-Current Assets across 8 years of filings, most recently posting $754.8 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $754.8 million, changed 0.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 billion (up 3.65% YoY), and the FY2025 annual result was $761.0 million, up 4.41% from the prior year.
• Non-Current Assets came in at $754.8 million for Q1 2026 at GoodRx Holdings, down from $761.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $772.8 million in Q2 2023 to a low of $543.6 million in Q1 2022.
• The 5-year median for Non-Current Assets is $728.0 million (2024), against an average of $720.5 million.
• Across the five-year window, Non-Current Assets jumped 40.25% in 2022 and slipped 6.21% in 2024, its largest moves.
• GoodRx Holdings' Non-Current Assets stood at $684.9 million in 2022, then climbed by 4.54% to $716.0 million in 2023, then advanced by 1.79% to $728.8 million in 2024, then grew by 4.41% to $761.0 million in 2025, then decreased by 0.81% to $754.8 million in 2026.
• The last three Non-Current Assets figures came in at $754.8 million (Q1 2026), $761.0 million (Q4 2025), and $760.0 million (Q3 2025), per Business Quant data.